BEKE-W (02423) Reports No Share Issuance; Repurchases Reach 106.19 Million Shares under 2025 Mandate

Bulletin Express03-12

KE Holdings Inc. (HKEX: 02423; “BEKE-W”) filed a Next Day Disclosure Return on 12 March 2026 confirming that its issued share capital remained unchanged at 3.39 billion Class A ordinary shares as of 11 March 2026. Including 138.59 million Class B ordinary shares, the company’s total issued share count stays at 3.53 billion.

The filing details 687,045 Class A shares repurchased on 11 March 2026 through the New York Stock Exchange at prices ranging between USD 5.63 and USD 5.73, for a total consideration of USD 3.90 million. These shares are earmarked for cancellation.

Since the current repurchase mandate was approved on 27 June 2025, BEKE-W has bought back 106.19 million shares—equivalent to 2.95 % of the issued share base at the date of mandate approval—out of an authorised limit of 360.22 million shares. The cumulative repurchases disclosed but not yet cancelled now stand at 16.61 million shares, acquired between 2 January and 11 March 2026 at volume-weighted average prices ranging from USD 5.43 to USD 6.10 per share.

Under Hong Kong Listing Rules, BEKE-W is subject to a moratorium on issuing new shares or transferring treasury shares until 10 April 2026 following the latest repurchase activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment